Tag: investing in biotech stocks
3 Biotech Stocks That Can Double Before The End Of 2016
And, that is no exaggeration, these three biotech stocks all have near-term catalysts right around the corner that will send their currently undervalued share prices soaring when positive. Grab shares today because the catalysts we’re targeting for growth start happening in September. One of the keys to investing in the small cap portion of the […]
4 Undervalued Growth Stocks Deserving Your Interest
Pick up your pen and paper and write down the names of these four stocks that right now trade for valuations too low for their potential growth. With most stocks tading for premiums right now, finding four growth stocks with attractive valuations to add to your portfolio is worth your attention. I have followed and […]
4 Stocks To Buy With The Spread Of Zika
The Zika virus has been all over the news recently. It obviously is a backdrop for the Summer Olympics given the host country Brazil is the epicenter for this recent outbreak. The President and Congress continue to duel it out on assigning funding to tackle the virus from spreading further than it already has in […]
Buy These 5 Undervalued Biotech Stocks On Sale Today
One, two, or three years out, investors will probably look back on the entry points in these five stocks and wonder why they did not allocate more funds to them. With growing earnings and revenues and M&A heating up, these five stocks are screaming buys right now. I was out at the Money Show in […]
3 Undervalued Biotech Stocks With Upcoming Catalysts
New drug approvals and the rollout of just-commercialized products will be the catalysts that send these undervalued stocks rallying. Negative sentiment has dropped their prices so low that any rally from these prices could return investors explosive gains. Despite four straight weeks of gains in the S&P 500, the biotech sector continues to be mired […]
4 Undervalued Bargains To Buy In Biotech
Editor’s Note: This article discusses opportunities in the biotech space, which is often populated with small and micro cap stocks. Sporting their cheapest valuations since 2011 and superior long-term values over the rest of the market, now is the time to shop the bargain bin in biotech. See Bret Jensen’s top four picks to start […]
